publication venue for
- Nanoscale implant anchorage aided by cement line deposition into titanium dioxide nanotubes. 111:1866-1874. 2023
- Mucoadhesive thermogel platform for treating anterior ocular conditions. 111:1390-1405. 2023
-
Fetuin‐
A adsorption to tunable polydimethylsiloxane and subsequent macrophage response. 111:1096-1109. 2023 - Property modelling of lysozyme‐crosslinker‐alginate complexes using latent variable methods. 109:2225-2236. 2021
- In vitro evaluation of novel titania‐containing borate bioactive glass scaffolds. 109:146-158. 2021
- Capsaicin reduces PLGA‐induced fibrosis by promoting M2 macrophages and suppressing overall inflammatory Response. 106:2424-2432. 2018
- Poly(ethylene glycol)‐or silicone‐modified hyaluronan for contact lens wetting agent applications. 103:2602-2610. 2015
- An investigation of scavenger receptor A mediated leukocyte binding to polyanionic and uncharged polymer hydrogels. 103:1605-1612. 2015
- Transient inhibition of connective tissue infiltration and collagen deposition into porous poly(lactic‐co‐glycolic acid) discs. 101:3599-3606. 2013
- The recognition of biomaterials: Pattern recognition of medical polymers and their adsorbed biomolecules. 101A:2740-2752. 2013
- Measuring the kinetics and activity of adsorbed proteins: In vitro lysozyme deposited onto hydrogel contact lenses over short time periods. 101A:755-764. 2013
- Polyurethane modified with an antithrombin‐heparin complex via polyethylene oxide linker/spacers: Influence of PEO molecular weight and PEO‐ATH bond on catalytic and direct anticoagulant functions. 100A:2821-2828. 2012
- Heparin‐modified dendrimer crosslinked collagen matrices for the delivery of heparin‐binding epidermal growth factor. 100A:1929-1937. 2012
- Photocrosslinkable hyaluronic acid as an internal wetting agent in model conventional and silicone hydrogel contact lenses. 100A:1972-1982. 2012
- An investigation into the effect of amphiphilic siloxane oligomers on dermal fibroblasts. 100A:1919-1927. 2012
- Cell‐adhesive thermogelling PNIPAAm/hyaluronic acid cell delivery hydrogels for potential application as minimally invasive retinal therapeutics. 100A:1877-1887. 2012
- Dual surface modification with PEG and corn trypsin inhibitor: Effect of PEG:CTI ratio on protein resistance and anticoagulant properties. 100A:856-862. 2012
- Interfacial interactions of apolipoprotein AI and high density lipoprotein: Overlooked phenomena in blood‐material contact. 99A:109-115. 2011
- Immunoblot analysis of proteins associated with self‐assembled monolayer surfaces of defined chemistries. 98A:7-18. 2011
- Protein‐resistant polyurethane by sequential grafting of poly(2‐hydroxyethyl methacrylate) and poly(oligo(ethylene glycol) methacrylate) via surface‐initiated ATRP. 95A:1223-1232. 2010
- Corneal epithelial cell adhesion and growth on EGF‐modified aminated PDMS. 93A:1043-1049. 2010
- Rheological blends for drug delivery. I. Characterization in vitro. 92A:575-585. 2010
- Rheological blends for drug delivery. II. Prolongation of nerve blockade, biocompatibility, and in vitro–in vivo correlations. 92A:586-595. 2010
- Protein‐resistant polyurethane via surface‐initiated atom transfer radical polymerization of oligo(ethylene glycol) methacrylate. 91A:1189-1201. 2009
- Surfaces having dual fibrinolytic and protein resistant properties by immobilization of lysine on polyurethane through a PEG spacer. 90A:940-946. 2009
- Effect of alginate on innate immune activation of macrophages. 90A:411-418. 2009
- Nonfouling biomaterials based on polyethylene oxide‐containing amphiphilic triblock copolymers as surface modifying additives: Adsorption of proteins from human plasma to copolymer/polyurethane blends. 90A:196-204. 2009
- Nonfouling biomaterials based on polyethylene oxide‐containing amphiphilic triblock copolymers as surface modifying additives: Protein adsorption on PEO‐copolymer/polyurethane blends. 85A:873-880. 2008
- Nonfouling biomaterials based on polyethylene oxide‐containing amphiphilic triblock copolymers as surface modifying additives: Solid state structure of PEO‐copolymer/polyurethane blends. 85A:862-872. 2008
- Fibrinolytic properties of lysine‐derivatized polyethylene in contact with flowing whole blood (Chandler loop model). 81A:644-651. 2007
- Fibrinogen adsorption and platelet lysis characterization of fluorinated surface‐modified polyetherurethanes. 81A:178-185. 2007
- Protein adsorption on polyurethane catheters modified with a novel antithrombin‐heparin covalent complex. 80A:216-225. 2007
- A novel tool for high‐resolution transmission electron microscopy of intact interfaces between bone and metallic implants. 78A:20-24. 2006
- Crosslinking of collagen with dendrimers. 75A:510-518. 2005
- Interactions of corneal cells with transforming growth factor β2‐modified poly dimethyl siloxane surfaces. 67A:981-993. 2003
- Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin. 67A:475-483. 2003
- Interactions of fibrinolytic system proteins with lysine-containing surf aces. 66A:795-801. 2003
- Interactions of fibrinolytic system proteins with lysine‐containing surfaces. 66A:795-801. 2003